Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rona Yaeger

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|October 8, 2019
Heterogeneity in Microsatellite Instability in Metastatic Colorectal Cancer: Mechanisms and Clinical ImplicationsRona Yaeger
The New England Journal of Medicine|December 6, 2023
Combination Therapy and Appropriate Dosing to Target KRAS in Colorectal CancerRona Yaeger
Abdominal Radiology (New York)|May 11, 2019
Genetics of rectal cancer and novel therapies: primer for radiologistsSebastian Mondaca, Rona Yaeger
Current Opinion in Pharmacology|January 13, 2023
KRAS inhibition in metastatic colorectal cancer: An updateMaliha Nusrat, Rona Yaeger
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapyRona Yaeger, Leonard Saltz
Annals of Translational Medicine|June 19, 2018
Colorectal cancer genomics and designing rational trialsSebastian Mondaca, Rona Yaeger
Journal of Gastrointestinal Oncology|December 24, 2015
Impact of somatic mutations on patterns of metastasis in colorectal cancerMarla Lipsyc, Rona Yaeger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2020
Overcoming Adaptive Resistance to KRAS Inhibitors Through Vertical Pathway TargetingRona Yaeger, David B Solit
Cancer Discovery|February 17, 2019
Targeting Alterations in the RAF-MEK PathwayRona Yaeger, Ryan B Corcoran
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2015
RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer-ResponseRona Yaeger, Leonard B Saltz
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Journal of the National Comprehensive Cancer Network : JNCCN|October 8, 2019
Heterogeneity in Microsatellite Instability in Metastatic Colorectal Cancer: Mechanisms and Clinical ImplicationsRona Yaeger
The New England Journal of Medicine|December 6, 2023
Combination Therapy and Appropriate Dosing to Target KRAS in Colorectal CancerRona Yaeger
Abdominal Radiology (New York)|May 11, 2019
Genetics of rectal cancer and novel therapies: primer for radiologistsSebastian Mondaca, Rona Yaeger
Current Opinion in Pharmacology|January 13, 2023
KRAS inhibition in metastatic colorectal cancer: An updateMaliha Nusrat, Rona Yaeger
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapyRona Yaeger, Leonard Saltz
Annals of Translational Medicine|June 19, 2018
Colorectal cancer genomics and designing rational trialsSebastian Mondaca, Rona Yaeger
Journal of Gastrointestinal Oncology|December 24, 2015
Impact of somatic mutations on patterns of metastasis in colorectal cancerMarla Lipsyc, Rona Yaeger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2020
Overcoming Adaptive Resistance to KRAS Inhibitors Through Vertical Pathway TargetingRona Yaeger, David B Solit
Cancer Discovery|February 17, 2019
Targeting Alterations in the RAF-MEK PathwayRona Yaeger, Ryan B Corcoran
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2015
RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer-ResponseRona Yaeger, Leonard B Saltz
Pageof 18